Komori
Kaken Pharmaceutical (4521) · InitiativeRestated

Business optimisation, efficiency improvements and lower cost ratios

First written in FY2017. 6 of 7 entries say "Restated". Latest entry: FY2022.

7entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY20222017: 120172018: 120182019: 120192020: 020202021: 220212022: 22022
Same theme, other companies
Profitability Improvement through Rationalization, Cost Reduction and Productivity ImprovementA theme 95 companies write about · 0 as a headwind · 98 as a tailwind

15 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 95 companies compared. The sentences above are computed from all 95.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「Going forward, we will actively promote work-style reform and work to improve productivity by developing and expanding flexible working hours, staggered working hours, telecommuting, and remote-work environments using ICT (information and communications technology).」

    The company continues to improve productivity through flexible working arrangements, telecommuting, and the development and expansion of ICT-enabled remote-work environments.
  2. FY2022-Q3RestatedAnnual report

    「Going forward, we will actively promote work-style reform and work to improve productivity by developing and expanding flexible working hours, staggered working hours, telecommuting, and remote-work environments using ICT (information and communications technology).」

    The policy of improving productivity through the development and expansion of flexible working hours, staggered working hours, telecommuting, and ICT-enabled remote-work environments continues.
  3. FY2022-Q2RestatedAnnual report

    「Going forward, we will actively promote work-style reform and work to improve productivity by developing and expanding flexible working hours, staggered working hours, telecommuting, and remote-work environments using ICT (information and communications technology).」

    The policy of improving productivity through the development and expansion of flexible working hours, staggered working hours, telecommuting, and ICT-enabled remote-work environments continues.
  4. FY2021RestatedAnnual report

    「We are also working to improve productivity by strengthening our sales platform, promoting talent development and training, streamlining the organisation, and optimising staffing, among other initiatives.」

    The company continues to review its sales platform, talent and organisational structure and staffing in pursuit of higher productivity.
  5. FY2019RestatedAnnual report

    「In production, we will improve the efficiency of capital investment, optimise staffing, review products and specifications, and work to reduce cost ratios further.」

    The policy of optimising and improving operating efficiency and reducing cost ratios through capital investment, staffing, and product and specification reviews continues.
  6. FY2018RestatedAnnual report

    「In production, we will improve the efficiency of capital investment, optimise staffing, review products and specifications, and work to reduce cost ratios further.」

    The policy of improving operating efficiency and reducing cost ratios through capital investment, staffing, and product and specification reviews continues.
  7. FY2017First statedAnnual report

    「In production, we will improve the efficiency of capital investment, optimise staffing, review products and specifications, and work to reduce cost ratios further. For agricultural chemicals, we are progressing with the outsourcing of production to overseas companies.」

    The company identified as initiatives the reduction of cost ratios through capital investment, staffing and product and specification reviews, as well as the outsourcing of agricultural chemical production to overseas companies.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Kaken Pharmaceutical's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.